Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension

This study has been terminated.

( Difficulty finding the required subject population )

Study NCT00637403 Information provided by Par Pharmaceutical, Inc.

First Received: March 11, 2008 Last Updated: March 17, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2006
Primary Completion Date:	May 2006 (Final data collection date for primary outcome measure)